Literature DB >> 16281180

Albumin depletion of human plasma also removes low abundance proteins including the cytokines.

Jill Granger1, Javed Siddiqui, Shannon Copeland, Daniel Remick.   

Abstract

The use of proteomics for efficient, accurate, and complete analysis of clinical samples poses a variety of technical challenges. The presence of higher abundance proteins in the plasma, such as albumin, may mask the detection of lower abundance proteins such as the cytokines. Methods have been proposed to deplete the sample of these higher abundance proteins to facilitate detection of those with lower abundance. In this study, a commercially available albumin depletion kit was used to determine if removal of albumin would measurably reduce detection of lower abundance cytokine proteins in human plasma. The Montage Albumin Deplete Kit (Millipore) was used to deplete albumin from LPS-stimulated whole blood from 15 normal human donors. Albumin depletion was measured using the BCG reagent and SDS-PAGE, and cytokine recovery was determined by a microassay immunoassay that measures both pro- and anti-inflammatory cytokines. Average albumin depletion from the samples was 72%. However, several cytokines were also significantly reduced when the albumin was removed from the plasma. Additionally, there was a variable reduction in cytokine recovery from a known mixture of cytokines in a minimal amount of plasma that were loaded onto the columns. These data demonstrate that there may be a non-specific loss of cytokines following albumin depletion, which may confound subsequent proteomic analysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16281180     DOI: 10.1002/pmic.200401331

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  48 in total

1.  Clinical proteomics: present and future prospects.

Authors:  Nicole M Verrills
Journal:  Clin Biochem Rev       Date:  2006-05

2.  Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests.

Authors:  Tanguy Fortin; Arnaud Salvador; Jean Philippe Charrier; Cristof Lenz; Xavier Lacoux; Aymeric Morla; Geneviève Choquet-Kastylevsky; Jérôme Lemoine
Journal:  Mol Cell Proteomics       Date:  2008-12-08       Impact factor: 5.911

Review 3.  Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.

Authors:  Aarti Rana; Shweta Thakur; Girish Kumar; Yusuf Akhter
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

Review 4.  Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.

Authors:  Robert E Gerszten; Frank Accurso; Gordon R Bernard; Richard M Caprioli; Eric W Klee; George G Klee; Iftikhar Kullo; Theresa A Laguna; Frederick P Roth; Marc Sabatine; Pothur Srinivas; Thomas J Wang; Lorraine B Ware
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

Review 5.  Two-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.

Authors:  Leila H Choe; Brenda G Werner; Kelvin H Lee
Journal:  NeuroRx       Date:  2006-07

6.  Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers.

Authors:  Brianna Kim; Robyn Araujo; Marissa Howard; Ruben Magni; Lance A Liotta; Alessandra Luchini
Journal:  Expert Rev Proteomics       Date:  2018-03-22       Impact factor: 3.940

7.  Biomarker discovery in animal health and disease: the application of post-genomic technologies.

Authors:  Rowan E Moore; Jennifer Kirwan; Mary K Doherty; Phillip D Whitfield
Journal:  Biomark Insights       Date:  2007-07-10

8.  Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis.

Authors:  Kaushal S Gandhi; Fiona C McKay; Eve Diefenbach; Ben Crossett; Stephen D Schibeci; Robert N Heard; Graeme J Stewart; David R Booth; Jonathan W Arthur
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

9.  Endogenous plasma Peptide detection and identification in the rat by a combination of fractionation methods and mass spectrometry.

Authors:  Fabrice Bertile; Flavie Robert; Véronique Delval-Dubois; Sarah Sanglier; Christine Schaeffer; Alain Van Dorsselaer
Journal:  Biomark Insights       Date:  2007-10-09

10.  Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies.

Authors:  Christoph Schröder; Anette Jacob; Sarah Tonack; Tomasz P Radon; Martin Sill; Manuela Zucknick; Sven Rüffer; Eithne Costello; John P Neoptolemos; Tatjana Crnogorac-Jurcevic; Andrea Bauer; Kurt Fellenberg; Jörg D Hoheisel
Journal:  Mol Cell Proteomics       Date:  2010-02-16       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.